Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis

• Fabiola Traina,

  Affiliations Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Hematology and Hemotherapy Center, INCT do Sangue, University of Campinas, Campinas, São Paulo, Brazil

  ⨯
• Valeria Visconte,

  Affiliation Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Anna M. Jankowska,

  Affiliation Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Hideki Makishima,

  Affiliation Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Christine L. O’Keefe,

  Affiliation Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Paul Elson,

  Affiliation Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Yingchun Han,

  Affiliation Department of Pathobiology, Lerner Research Institute and Allergy and Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Fred H. Hsieh,

  Affiliation Department of Pathobiology, Lerner Research Institute and Allergy and Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Mikkael A. Sekeres,

  Affiliations Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Raghuveer Singh Mali,

  Affiliation Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University of School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Matt Kalaycio,

  Affiliation Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Alan E. Lichtin,

  Affiliation Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Anjali S. Advani,

  Affiliation Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Hien K. Duong,

  Affiliation Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Edward Copelan,

  Affiliation Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Reuben Kapur,

  Affiliation Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University of School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Sara T. Olalla Saad,

  Affiliation Hematology and Hemotherapy Center, INCT do Sangue, University of Campinas, Campinas, São Paulo, Brazil

  ⨯
• Jaroslaw P. Maciejewski,

  Affiliations Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
•  [ ... ],
• Ramon V. Tiu

  * E-mail: tiur@ccf.org

  Affiliations Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• [ view all ]
• [ view less ]